Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

Samaritan Biologics plans to open a $5 million, 11,000-square-foot manufacturing facility on its CU-ICAR campus.

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

Biologics are a class of drugs used to treat various diseases to help improve outcomes. Understanding the options can help you work with your doctor to make informed treatment decisions.

Samaritan Biologics, a medical technology company, announced that it is expanding its operations in Greenville, creating 85 ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Wong, Founder and CEO of HCW Biologics, stated, "In the third quarter 2024, the Company expanded our product portfolio and ...

Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...

Opens in a new tab or window Researchers and experts at the recent American College of Allergy, Asthma & Immunology (ACAAI) ...

Understanding what to patent versus what to keep as a trade secret is an increasingly important and challenging decision ...

Dozens of jobs are coming to Greenville County, South Carolina, with the $5 million expansion of a company, officials ...

Shares of Omeros touched a 52-week high, a day after the company said it could resubmit its biologics license application for narsoplimab to the Food and Drug Administration. In Thursday afternoon ...